Evidence map›Paper›PMID 38994947›Full record

ArticleCells2024

The Role of Vimentin in Human Corneal Fibroblast Spreading and Myofibroblast Transformation.

Miguel Miron-Mendoza, Kara Poole, Sophie DiCesare, Emi Nakahara, Meet Paresh Bhatt, John D Hulleman, Walter Matthew Petroll

Abstract read
In one paragraph

Article in Cells, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Update on the Physiopathology of Keratoconus.Medical sciences (Basel, Switzerland) · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Vimentin - Force regulator in confined environments.Current opinion in cell biology · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. The role of the cytoskeleton in fibrotic diseases.Frontiers in cell and developmental biology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Miguel Miron-MendozaDepartment of Ophthalmology, UT Southwestern Medical Center, Dallas, TX 75390, USA.
Kara PooleDepartment of Ophthalmology, UT Southwestern Medical Center, Dallas, TX 75390, USA.ORCID 0000-0002-4104-0370
Sophie DiCesareDepartment of Ophthalmology, UT Southwestern Medical Center, Dallas, TX 75390, USA.
Emi NakaharaDepartment of Ophthalmology, UT Southwestern Medical Center, Dallas, TX 75390, USA.
Meet Paresh BhattDepartment of Ophthalmology, UT Southwestern Medical Center, Dallas, TX 75390, USA.
John D HullemanDepartment of Ophthalmology, UT Southwestern Medical Center, Dallas, TX 75390, USA.
Walter Matthew PetrollDepartment of Ophthalmology, UT Southwestern Medical Center, Dallas, TX 75390, USA.ORCID 0000-0003-0795-4539

Funding

Assessment of Corneal Fibroblast Biomechanical BehaviorR01EY013322 · NEI · UT SOUTHWESTERN MEDICAL CENTER · PI PETROLL, W MATTHEW · 2001 to 2025
$9.0M
Stem Cell, Organoid and Cell Phenotyping ModuleP30EY030413 · NEI · UT SOUTHWESTERN MEDICAL CENTER · PI W MATTHEW PETROLL · 2019 to 2026
$5.9M
NEI NIH HHS P30 EY030413NEI NIH HHS R01 EY013322NIH HHS P30 EY030413NIH HHS R01 EY013322Research to Prevent Blindness Challenge Grant
6 · The paper itself

Abstract

Vimentin has been reported to play diverse roles in cell processes such as spreading, migration, cell-matrix adhesion, and fibrotic transformation. Here, we assess how vimentin impacts cell spreading, morphology, and myofibroblast transformation of human corneal fibroblasts. Overall, although knockout (KO) of vimentin did not dramatically impact corneal fibroblast spreading and mechanical activity (traction force), cell elongation in response to PDGF was reduced in vimentin KO cells as compared to controls. Blocking vimentin polymerization using Withaferin had even more pronounced effects on cell spreading and also inhibited cell-induced matrix contraction. Furthermore, although absence of vimentin did not completely block TGFβ-induced myofibroblast transformation, the degree of transformation and amount of αSMA protein expression was reduced. Proteomics showed that vimentin KO cells cultured in TGFβ had a similar pattern of protein expression as controls. One exception included periostin, an ECM protein associated with wound healing and fibrosis in other cell types, which was highly expressed only in Vim KO cells. We also demonstrate for the first time that LRRC15, a protein previously associated with myofibroblast transformation of cancer-associated fibroblasts, is also expressed by corneal myofibroblasts. Interestingly, proteins associated with LRRC15 in other cell types, such as collagen, fibronectin, β1 integrin and α11 integrin, were also upregulated. Overall, our data show that vimentin impacts both corneal fibroblast spreading and myofibroblast transformation. We also identified novel proteins that may regulate corneal myofibroblast transformation in the presence and/or absence of vimentin.

Indexed as

CorneaFibroblastsMyofibroblastsVimentinCell MovementCells, CulturedHumansTransforming Growth Factor betaWithanolidesTransforming Growth Factor betaVimentinwithaferin AWithanolidescorneacytoskeletonfibroblastsmyofibroblastsPDGFTGFβvimentinwound healing

Identifiers

PMID38994947
PMCPMC11240817

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.